NCT00400569 2012-08-28Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue SarcomaH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Completed48 enrolled 9 charts